Savara Inc. (SVRA)
NASDAQ: SVRA · Real-Time Price · USD
5.26
+0.10 (1.94%)
Feb 6, 2026, 1:28 PM EST - Market open
Savara Employees
Savara had 59 employees as of December 31, 2024. The number of employees increased by 22 or 59.46% compared to the previous year.
Employees
59
Change (1Y)
22
Growth (1Y)
59.46%
Revenue / Employee
n/a
Profits / Employee
-$1,960,085
Market Cap
1.30B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,500 |
| Novavax | 952 |
| Immatics | 645 |
| Capricor Therapeutics | 160 |
| AnaptysBio | 136 |
| Kodiak Sciences | 123 |
| DBV Technologies | 117 |
| Taysha Gene Therapies | 73 |
SVRA News
- 1 day ago - Savara Announces Participation in Upcoming Investor Healthcare Conferences - Business Wire
- 10 days ago - Savara Announces Amendment to Hercules Capital Debt Facility Providing up to $75M of Additional Debt Funding Upon U.S. Food and Drug Administration (FDA) Approval of MOLBREEVI* - Business Wire
- 20 days ago - Savara Announces New Employment Inducement Grant - Business Wire
- 22 days ago - Savara Inc. (SVRA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - PANTHERx® Rare Selected by Savara as the U.S. Exclusive Specialty Pharmacy for MOLBREEVI* - Business Wire
- 6 weeks ago - Savara Resubmits the Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for MOLBREEVI* for the Potential Treatment of Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP) - Business Wire
- 7 weeks ago - Savara Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference - Business Wire
- 2 months ago - Savara Announces European Patent Office (EPO) Intends to Grant a Patent for the Liquid Formulation of MOLBREEVI* - Business Wire